PRA Health Sciences and Alliance for Multispecialty Research (AMR) have partnered to develop a new approach to vaccine studies that will allow them to run more efficiently and effectively.   PRA’s vaccine experience includes Phase I-IV adult and pediatric studies and has provided clinical development support for ten approved vaccines over the past five years, and supports four of the five top vaccine manufacturers.   AMR has vaccine trial experience for a variety of indications, includ...